![Efficacy of higher-dose edoxaban in the intention-to-treat population... | Download Scientific Diagram Efficacy of higher-dose edoxaban in the intention-to-treat population... | Download Scientific Diagram](https://www.researchgate.net/publication/272520359/figure/fig2/AS:601799908159506@1520491687783/Efficacy-of-higher-dose-edoxaban-in-the-intention-to-treat-population-stratified-by-prior.png)
Efficacy of higher-dose edoxaban in the intention-to-treat population... | Download Scientific Diagram
![Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation - ScienceDirect Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109721000085-fx1.jpg)
Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation - ScienceDirect
![Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation | Journal of the American College of Cardiology Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/1f45932f-aaf9-4314-844f-9341568eff58/fx1.jpg)
Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation | Journal of the American College of Cardiology
![Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial - The Lancet Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial - The Lancet](https://www.thelancet.com/cms/attachment/2069221902/2067612249/gr1.gif)
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial - The Lancet
![Edoxaban dosing patterns in real life practice – Results from the DRESDEN NOAC REGISTRY - ScienceDirect Edoxaban dosing patterns in real life practice – Results from the DRESDEN NOAC REGISTRY - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666572721000390-gr1.jpg)
Edoxaban dosing patterns in real life practice – Results from the DRESDEN NOAC REGISTRY - ScienceDirect
![Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial | Hypertension Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial | Hypertension](https://www.ahajournals.org/cms/asset/22b97e43-c655-4097-bb81-150d156d5272/597ga1.jpg)
Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial | Hypertension
![Brain Sciences | Free Full-Text | Prospective Observational Study of Safety of Early Treatment with Edoxaban in Patients with Ischemic Stroke and Atrial Fibrillation (SATES Study) Brain Sciences | Free Full-Text | Prospective Observational Study of Safety of Early Treatment with Edoxaban in Patients with Ischemic Stroke and Atrial Fibrillation (SATES Study)](https://www.mdpi.com/brainsci/brainsci-11-00030/article_deploy/html/images/brainsci-11-00030-g001.png)
Brain Sciences | Free Full-Text | Prospective Observational Study of Safety of Early Treatment with Edoxaban in Patients with Ischemic Stroke and Atrial Fibrillation (SATES Study)
![Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min - Yin - 2022 - Clinical Pharmacology in Drug Development - Wiley Online Library Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min - Yin - 2022 - Clinical Pharmacology in Drug Development - Wiley Online Library](https://accp1.onlinelibrary.wiley.com/cms/asset/5a14f960-74cf-4045-b181-805e9df7449d/cpdd1050-fig-0001-m.jpg)
Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min - Yin - 2022 - Clinical Pharmacology in Drug Development - Wiley Online Library
![Table 1 from Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. | Semantic Scholar Table 1 from Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b141e8c36fd0ceaec628488a500cd5aad3141e4d/4-Table1-1.png)